Modified chop-chemotherapy plus rituximab for diffuse large B-cell lymphoma complicating ataxia-telangiectasia [3]

British Journal of Haematology

Volumn 120, Issue 2, 2003, Pages 369-371

  Rossi, Gabriele ^a   Zecca, Marco ^a   Marchi, Antonietta ^a   De Stefano, Piero ^a   Sammarchi, Luigi ^a   Locatelli, Franco ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Ataxia telangiectasia; Modified CHOP chemotherapy; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN DERIVATIVE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ATAXIA TELANGIECTASIA; AUTOSOMAL RECESSIVE DISORDER; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER SUSCEPTIBILITY; CASE REPORT; CHROMOSOME FRAGILITY; DNA REPAIR; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HUMAN; LABORATORY TEST; LARGE CELL LYMPHOMA; LETTER; PRIORITY JOURNAL; RADIODIAGNOSIS; REMISSION; SIDE EFFECT;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATAXIA TELANGIECTASIA; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; MAGNETIC RESONANCE IMAGING; MAXILLARY SINUS; MAXILLARY SINUS NEOPLASMS; PREDNISONE; REMISSION INDUCTION; VINCRISTINE;

EID: 0037275531     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04041_4.x     Document Type: Letter

References (6)

1. Abadir, R. & Hakamin, N. (1983) Ataxia telangiectasia with cancer: an indication for reduced radiotherapy and chemotherapy doses. British Journal of Radiology, 56, 343-344.
2. Coiffier, B., Lepade, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F., Lederlin, P., Lederlin, P. & Gisselbrecht, C. (2002) CHOP chemotherapy plus Rituximab compared with CHOP alone in elderly patients with diffuse large-B cell lymphoma. New England Journal of Medicine, 346, 235-242.
3. Cook, R.C., Connors, J.M., Gascoyne, R.D., Fradet, G. & Levy, R.D. (1999) Treatment of post-transplant lymproliferative disease with rituximab monoclonal antibody after lung transplantation. Lancet, 354, 1698-1699.
4. Gatti, R.A. (1995) Ataxia telangiectasia. Dermatologic Clinics, 13, 1-6.
5. Sandoval, C. & Swift, M. (1998) Treatment of lymphoid malignancies in patients with ataxia telangiectasia. Medical and Pediatric Oncology, 31, 491-497.
6. Weyl Ben Arush, M., Rosenthal, J., Dale, J., Horovitch, Y., Herlz, G., Ben Arie, J., Ziv, Y. & Shilon, Y. (1995) Ataxia telangiectasia and lymphoma: an indication for individualized chemotherapy dosing: report of treatment in a highly inbred Arab family. Pediatric Hematology and Oncology, 12, 163-169.